Bender Robert & Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-9,342
| Closed | -$2.21M | – | 50 |
|
|
2019
Q1 | $2.21M | Sell |
9,342
-450
| -5% | -$106K | 1.08% | 26 |
|
|
2018
Q4 | $2.95M | Sell |
9,792
-72
| -0.7% | -$21.7K | 1.7% | 22 |
|
|
2018
Q3 | $3.49M | Hold |
9,864
| – | – | 1.59% | 23 |
|
|
2018
Q2 | $2.86M | Buy |
9,864
+31
| +0.3% | +$9K | 1.5% | 23 |
|
|
2018
Q1 | $2.69M | Buy |
9,833
+349
| +4% | +$95.5K | 1.5% | 24 |
|
|
2017
Q4 | $3.02M | Sell |
9,484
-117
| -1% | -$37.3K | 1.67% | 24 |
|
|
2017
Q3 | $3.01M | Buy |
9,601
+266
| +3% | +$83.3K | 1.73% | 23 |
|
|
2017
Q2 | $2.53M | Buy |
9,335
+99
| +1% | +$26.9K | 1.55% | 22 |
|
|
2017
Q1 | $2.53M | Sell |
9,236
-222
| -2% | -$60.7K | 1.63% | 22 |
|
|
2016
Q4 | $2.68M | Sell |
9,458
-423
| -4% | -$120K | 1.9% | 21 |
|
|
2016
Q3 | $3.09M | Buy |
9,881
+569
| +6% | +$178K | 2.04% | 21 |
|
|
2016
Q2 | $2.25M | Sell |
9,312
-219
| -2% | -$53K | 1.59% | 23 |
|
|
2016
Q1 | $2.48M | Sell |
9,531
-112
| -1% | -$29.2K | 1.68% | 24 |
|
|
2015
Q4 | $2.95M | Sell |
9,643
-1,418
| -13% | -$434K | 1.89% | 20 |
|
|
2015
Q3 | $3.23M | Sell |
11,061
-71
| -0.6% | -$20.7K | 2.18% | 19 |
|
|
2015
Q2 | $4.5M | Buy |
11,132
+86
| +0.8% | +$34.7K | 2.67% | 15 |
|
|
2015
Q1 | $4.66M | Buy |
+11,046
| New | +$4.66M | 2.72% | 16 |
|